Clinical Trial Update: Eosinophil-guided Reduction of Inhaled Corticosteroids [Phase 4]

View source ↗

Summary

Phase 4 COPD trial investigating eosinophil-guided reduction of inhaled corticosteroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark | Conditions: COPD, Inhaled Corticosteroid | Phase 4 | Status: COMPLETED